Source MS Society: Researchers at the University of Cambridge have found a new way to repairmyelin using a well-established treatment for breast cancer. Tamoxifen has been used to treat breast cancer since the early 1970s, but research has revealed some previously unknown benefits of the treatment. Read on.
Posts By: Sue
July 100 club winners
July 100 club winners: 1st Tony Ball, 2nd Jill Goodall, 3rd John Day. See Sue or Dave for details on our 100 club, great odds
Learn about lastest research and living with MS 17-18 September – Excel Centre
Event organised by the MS Society in London, 17-8 September. Learning about latest research and living with MS. At the Excel Centre which is on the Docklands Light Railway, East London. http://www.oxfordmail.co.uk/news/14701420.Oxford_actress_calls_on_people_to_join_her_at_major_multiple_sclerosis_event/
Oxfordshire Clinical Commissioning Group
Oxfordshire Carers’ Strategy and Carers’ Personal Budgets Consultation You’ve been invited to participate in the Oxfordshire Carers’ Strategy and Carers’ Personal Budgets Consultation consultation by the consultation manager, Julia Stackhouse. This consultation is open from 24 Aug 2016 at 00:00 to 14 Nov 2016 at 23:59. Dear All Oxfordshire County Council and Oxfordshire Clinical Commissioning… Read more »
ILC Newsletter (August)
Contact the ILC Mon to Fri from 9-00 a.m. to 5-00 p.m. ( 01235 524857 :www.guidepostsilc.org.uk Home Page | ILC Oxfordshire www.guidepostsilc.org.uk Guideposts Independent Living Centre moved to Abingdon in April 2012. We are now based at the Abingdon Resource and Well-being Centre. Our contact number is: 01235 … The current… Read more »
One in 10 people with MS could face disability benefit cuts
Source MS Society: We’ve published new figures today which reveal the severe extent of possible benefits cuts for people living with MS. We estimate that more than a thousand people with MS have already had their benefits downgraded since Personal Independence Payment (PIP) replaced Disability Living Allowance (DLA) for some. Read on.
Encouraging results in secondary progressive MS trial
Source MS Trust: The EXPAND trial involved 1,651 people who took either siponimod or placebo capsules once a day for up to five years. A press release by Novartis, who make siponimod, announced that people on treatment took longer to show signs of progression than people on placebo. Progression was measured by EDSS scores taken… Read more »
Scientists have discovered never-before-seen vessels in the brain
Scientists have discovered never-before-seen vessels in the brain Source Science Alert: Scientists in the US have discovered a new series of lymphatic vessels in the body that link the brain to the immune system – a connection researchers had previously thought didn’t exist. The discovery could not only prompt a rewrite of the textbooks, it… Read more »
Researchers trick our cells into treating UTIs without antibiotics
Source: Science Alert New research shows that our bodies own immune systems have another way to fight off urinary tract infections (UTIs) without antibiotics – and it’s super effective. This is a pretty big deal, seeing as UTIs are one of the most common infections treated with antibiotics in humans – something that’s contributing to… Read more »
New Pre-HSCT Treatment May Make Stem Cell Transplants a Safer Option for MS Patients.
Source Multiple Sclerosis News Today: Scientists at Stanford University School of Medicine have developed a method for stem cell transplants that may do away with the need for prior systematic treatment with chemotherapy or radiotherapy. If successful, stem cell transplants could be an option for patients with multiple sclerosis (MS), an option now limited by… Read more »
